LCMS
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.
Pořadatel
Technology Networks
Technology Networks
Technology Networks zkoumá vědu, na které vám záleží, a poskytuje přístup k nejnovějším vědeckým zprávám, produktům, výzkumu, videím a posterům. Technology Networks je součástí LabX Media Group, která vlastní také Lab Manager, LabX a The Scientist. Technology Networks nabízí dnešním vědcům jediný zdroj, který obsahuje jedinečný, poutavý a zábavný obsah z oblasti jejich výzkumu.
Tagy
LC/MS
LinkedIn Logo

Advances in Drug Discovery & Development 2023 (Day 2)

ZÁZNAM | Proběhlo Čt, 28.9.2023
Nejnovější pokroky v oblasti objevování a vývoje malých molekul léčiv, biofarmacie a biotechnologie.
Přejít na webinář
LabRulez/AI: Advances in Drug Discovery & Development 2023
LabRulez/AI: Advances in Drug Discovery & Development 2023

This online event is aimed at those working within academia and pharmaceutical drug development, who want to hear from experts across their field. Focus will be given to the latest advances in small molecule drug discovery and development, biopharma and biotechnology.

This online symposium will cover:

  • Accelerating drug discovery through AI

  • Molecular dynamics simulations for novel drug targets

  • Allosteric small-molecule activation of PI 3-kinase for cardioprotection and neuroregeneration

  • Analytical solutions for challenging nitrosamine quantitation using LC-MS

  • Screening in organoids and complex 3D assays using high-content imaging

  • Paucity of novel oncology targets

  • An interactive Ask-Me-Anything session where you can pose your questions to thought leadership experts at the forefront of biopharmaceutical commerce

Agenda Day 2

16:00 – 16:30 Screening in Organoids & Complex 3D Assays Using High Content Imaging
  • Speaker: Michiel Fokkelman, PhD
16:30 – 16:40 Networking Break
16:40 – 17:00 Enhancing Safety and Quality Assurance in Cell Based Therapies and ATMPS: The Power of Rapid NAT-Based Mycoplasma Detection
  • Speaker: Michael Brewer
17:00 – 17:10 Networking Break
17:10 – 18:00 Call to Action: Critical Need to Address the Paucity of Novel Oncology Targets
  • Speaker: Brian D. Lamon, PhD
18:00 – 18:10 Networking Break
18:10 – 18:30 Target Discovery and Validation with Arrayed Cell Libraries
  • Speaker: Alexander Brown, PhD
18:30 – 18:40 Networking Break
18:40 – 19:30 To Improve the Selectivity and Sensitivity of Chimeric T-Cell Receptor for Treating Solid Tumours
  • Speaker: Chun Wu, PhD

Presenter: Joshua Smith, PhD (Global Lead for Industry Partnerships, IBM Research)

Presenter: Dr. Chun Wu (Associate Professor, Departments of Chemistry & Biochemistry and the Biological Biomedical Sciences – Rowan University)

Presenter: Dr. Bart Vanhaesebroeck (Professor, Cancer Institute, University College London)

Presenter: Dr. Grace Gong (Research Fellow, Cancer Institute, University College London)

Presenter: David Pardoe (SVP Global Molecular Architects, Evotec)

Presenter: Carla Marchioro (VP Scientific Director Global Molecular Architects, Evotec)

Presenter: Jack Steed (Senior Technical Marketing Specialist, Sciex)

Presenter: Michael Brewer (Director, Global Principal Consultant, Regulatory, BioProduction, Thermo Fisher Scientific)

Presenter: Michiel Fokkelman, PhD (Head of High Throughput Screening, Crown Bioscience Netherlands)

Presenter: Brian Lamon, PhD (Senior Vice President, Chief Business Officer and Head of BioPharma Business Development, Caris Life Sciences)

Presenter: Alexander Brown, PhD (Associate Director ECLIPSE Development, Synthego)

Presenter: Mike Ward (Global Head of Life Sciences & Healthcare Thought Leadership, Clarivate plc)

Technology Networks
LinkedIn Logo
 

Mohlo by Vás zajímat

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Aplikace
| 2026 | Thermo Fisher Scientific
Instrumentace
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Výrobce
Thermo Fisher Scientific
Zaměření
Metabolomika

Analysis of Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater

Aplikace
| 2026 | Agilent Technologies
Instrumentace
LC/MS, LC/MS/MS, LC/QQQ
Výrobce
Agilent Technologies
Zaměření
Životní prostředí

Non-Targeted Screening of Biosolids with the Xevo™ MRT Mass Spectrometer Reveals New Isoforms of PFAS

Aplikace
| 2026 | Waters
Instrumentace
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Výrobce
Waters
Zaměření
Životní prostředí

High Resolution Characterization of Lipid Nanoparticles Using the Xevo™ Charge Detection Mass Spectrometry (CDMS) Instrument - Single Particle Mass Analysis of Intact LNP-mRNA Formulations

Aplikace
| 2026 | Waters
Instrumentace
LC/MS, LC/MS/MS, LC/HRMS, Charakterizace částic, LC/IT
Výrobce
Waters
Zaměření
Lipidomika

Out-of-the-box workflow for PFAS quantitation using a fullscan high-resolution approach with the Orbitrap Exploris EFOX Mass Detector

Aplikace
| 2025 | Thermo Fisher Scientific
Instrumentace
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Výrobce
Thermo Fisher Scientific
Zaměření
Životní prostředí
Další projekty
GCMS
ICPMS
Sledujte nás
FacebookX (Twitter)LinkedInYouTube
Další informace
WebinářeO násKontaktujte násPodmínky užití
LabRulez s.r.o. Všechna práva vyhrazena. Obsah dostupný pod licencí CC BY-SA 4.0 Uveďte původ-Zachovejte licenci.